A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Rozanolixizumab Administered Subcutaneously Via Manual Push Versus Syringe Driver to Healthy Participants
Clinical trial NCT04828343 · COMPLETED
Trial details
- NCT number
- NCT04828343
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2022-04-11
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.